Curaleaf

All Curaleaf Retail Locations in New Jersey Have Elected to Unionize With United Food and Commercial Workers (UFCW) Union, Local 360

Retrieved on: 
Thursday, June 29, 2023
Labor, Advocacy Group Opinion, Tobacco, Cannabis, Public Policy, Government, State, Local, Retail, Natural Resources, United Food and Commercial Workers, Exercise, Curaleaf, Medically indigent adult, Food, UFCW, Sale, Drug

United Food and Commercial Workers (UFCW) Local 360 announces that, as it ramps up efforts to unionize New Jersey’s cannabis industry workers, all of Curaleaf’s New Jersey retail locations have been duly organized as members of UFCW.

Key Points: 
  • United Food and Commercial Workers (UFCW) Local 360 announces that, as it ramps up efforts to unionize New Jersey’s cannabis industry workers, all of Curaleaf’s New Jersey retail locations have been duly organized as members of UFCW.
  • The company’s retail locations, in Edgewater, Bellmawr and Bordentown, serve Medical and Adult-Use clients.
  • Employees at the three Curaleaf locations in New Jersey have certainly exhibited leadership qualities in choosing a bona fide union, like the UFCW, according to Giordano.
  • “Every Curaleaf employee in the state is joining the UFCW,” said Sam Ferraino, Jr., UFCW Local 360’s president.

Curaleaf Celebrates Launch of Adult Use Cannabis Sales in Maryland

Retrieved on: 
Thursday, June 29, 2023
Food, CSE, Cliq, Reisterstown, Maryland, Select, Patient, Grassroots, Drug, Hospital, Curaleaf

NEW YORK, June 29, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, announces it will begin adult use cannabis sales at all four of the company's Maryland dispensaries beginning July 1, the official first day of legal, adult use sales in the state. 

Key Points: 
  • NEW YORK, June 29, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, announces it will begin adult use cannabis sales at all four of the company's Maryland dispensaries beginning July 1, the official first day of legal, adult use sales in the state.
  • To celebrate the historic day, Curaleaf dispensaries in Montgomery Village, Frederick, Columbia and Reisterstown will host events featuring entertainment, food, swag and prizes.
  • "We're proud to be a part of this historic day in Maryland and serve the growing community of cannabis consumers across the region."
  • Welcoming adult use customers into Curaleaf's Maryland locations will not alter the company's commitment to its community of patients.

Curaleaf to Report First Quarter 2023 Financial and Operational Results

Retrieved on: 
Friday, May 5, 2023
Cannabis, Curaleaf, CSE, Drug, Cryptocurrency

NEW YORK, May 5, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the first quarter ended March 31, 2023 after market close on May 17, 2023.

Key Points: 
  • NEW YORK, May 5, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the first quarter ended March 31, 2023 after market close on May 17, 2023.
  • Management will host a conference call and audio webcast that afternoon at 5:00 p.m.
  • ET consisting of prepared remarks followed by a question and answer session related to the Company's operational and financial highlights.

Curaleaf Announces May Conference Participation

Retrieved on: 
Friday, May 5, 2023
Cannabis, CSE, Cryptocurrency, Curaleaf

NEW YORK, May 5, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA /OTCQX: CURLF ) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that members of Curaleaf's executive management team will be participating in the following investor community conferences and events during May 2023.

Key Points: 
  • NEW YORK, May 5, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA /OTCQX: CURLF ) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that members of Curaleaf's executive management team will be participating in the following investor community conferences and events during May 2023.
  • Matt Darin, Chief Executive Officer of Curaleaf, will be participating in the Cannabis Roundtable panel discussion from 2:35 – 3:00 PM EST.
  • Curaleaf management will also be hosting investor meetings.
  • Matt Darin, Chief Executive Officer of Curaleaf, will be participating in a fireside chat with Matt Bottomley from 1:00 – 1:25 PM EST.

Curaleaf to Report Fourth Quarter and Fiscal Year End 2022 Financial and Operational Results

Retrieved on: 
Wednesday, April 26, 2023
Cannabis, Curaleaf, CSE, Cryptocurrency

NEW YORK, April 26, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the fourth quarter and fiscal year ended December 31, 2022 after market close on May 1, 2023.

Key Points: 
  • NEW YORK, April 26, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the fourth quarter and fiscal year ended December 31, 2022 after market close on May 1, 2023.
  • Management will host a conference call and audio webcast that afternoon at 5:00 p.m.
  • ET consisting of prepared remarks followed by a question and answer session related to the Company's operational and financial highlights.

Curaleaf to Restate Certain Previously Issued 2022 and 2021 Financial Statements

Retrieved on: 
Wednesday, April 19, 2023
Interim, CSE, International, Audit committee, Bank statement, Curaleaf, Consultant, International Financial Reporting Standards, SEDAR, Form 6-K, Legislation, Cryptocurrency, Audit

NEW YORK, April 19, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), announced today that the Audit Committee of the Company's Board of Directors (the "Audit Committee"), with the assistance of outside counsel and consultants and in discussion with the Company's auditors, has been conducting, after internal review by management,  a review of certain purchases and sales of products through the Company's wholesale channel to determine whether they had commercial substance, and to confirm the timing and appropriateness of the recognition of revenue from those transactions, mainly in the last quarter of 2021 and the first and second quarters of 2022.

Key Points: 
  • Further to this review, the Company has determined that it will make certain adjustments to the revenue figures reported in its previously issued (i) audited annual consolidated financial statements for the fiscal year ended December 31, 2021 (the "2021 Annual Financial Statements") and (ii) unaudited interim consolidated financial statements for the first, second and third quarters of the fiscal year ended December 31, 2022 (collectively, the "2022 Interim Financial Statements"), as well as other related flow through adjustments.
  • In addition, Curaleaf determined that there were additional material weaknesses in its internal controls at the time of its prior financial statements.
  • The Company's 2021 Annual Financial Statements and 2022 Interim Financial Statements will be restated to effect the revenue adjustments described above, as well as other related flow through adjustments.
  • Curaleaf intends to file its audited annual consolidated financial statements for the fiscal year ended December 31, 2022 and related management's discussion and analysis by May 1st, 2023.

NJ CRC Board Reverses Itself and Fully Approves Curaleaf's Adult Use License Renewals After Legal Challenge

Retrieved on: 
Monday, April 17, 2023
Commission, State, Curaleaf, CSE, Secretary of State of New Jersey, CRC, New Jersey Cannabis Regulatory Commission

The CRC Board's decision came after first voting to vacate their decision from Thursday, April 13th, when they attempted to deny Curaleaf's adult use license renewals.

Key Points: 
  • The CRC Board's decision came after first voting to vacate their decision from Thursday, April 13th, when they attempted to deny Curaleaf's adult use license renewals.
  • In previously attempting not to renew Curaleaf's adult use licenses, the CRC Board had disregarded the Commission's staff recommendation to renew Curaleaf's adult use licenses and the fact that the company has no pending violations.
  • As part of the approval, Curaleaf will be providing the Commission with additional information regarding its labor practices and confirm its ongoing compliance with New Jersey law.
  • Curaleaf remains open for business and will continue working collaboratively with the CRC Board and its staff to ensure our good standing in the State of New Jersey."

CURALEAF COMMENTS ON NEW JERSEY CANNABIS REGULATORY COMMISSION'S BOARD DECISION

Retrieved on: 
Friday, April 14, 2023
Commission, New Jersey Cannabis Regulatory Commission, CSE, Secretary of State of New Jersey, CRC, Curaleaf

NEW YORK, April 14, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today commented on yesterday's decision New Jersey Cannabis Regulatory Commission's Board (the "CRC Board") to deny Curaleaf, one of the largest operators in the State of New Jersey, a renewal of its cultivation and retail licenses for adult-use.

Key Points: 
  • NEW YORK, April 14, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today commented on yesterday's decision New Jersey Cannabis Regulatory Commission's Board (the "CRC Board") to deny Curaleaf, one of the largest operators in the State of New Jersey, a renewal of its cultivation and retail licenses for adult-use.
  • "Today's unprecedented action by the New Jersey Cannabis Regulatory Commission's Board – which overrode the Commission's own staff recommendation that our adult use licenses be renewed – is very disappointing", said Boris Jordan, Chairman of Curaleaf.
  • "We believe the CRC Board has wrongly interpreted the applicable regulations and that its decision to retaliate against Curaleaf for our need to consolidate production into one local facility is lacking in merit".
  • Curaleaf is in good standing with the CRC and has fulfilled the requirements necessary for the renewal of our licenses."

Curaleaf Continues Retail and Brand Expansions in Florida

Retrieved on: 
Friday, April 14, 2023
Heart, CSE, JAMS, Cliq, Select, Creativity, Sunlight, Collection, Patient, Clematis Street Historic Commercial District, Cannabis, 151st Air Refueling Wing, Grassroots, Hospital, Drug, Curaleaf

NEW YORK, April 14, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the opening of Curaleaf Boca Raton Glades,  the company's 59th dispensary in Florida and 151st dispensary nationwide.  Located at 7875 Glades Rd, Boca Raton, FL 33434, Curaleaf Boca Raton Glades is the first of two new locations to open in the Sunshine State this month. The company will open its 60thFlorida dispensary, Curaleaf West Palm Beach, 300 Clematis St, West Palm Beach, FL 33401, by the end of the month pending regulatory approvals.

Key Points: 
  • The company will open its 60thFlorida dispensary, Curaleaf West Palm Beach, 300 Clematis St, West Palm Beach, FL 33401, by the end of the month pending regulatory approvals.
  • Curaleaf continues to prioritize the Florida market through the expansion of its retail footprint and the continued innovation of its assortment of products and brands.
  • Bringing creativity to cultivation, Grassroots is a Chicago-born premium brand that celebrates cannabis and community in their most honest forms.
  • Patients at all Curaleaf locations in Florida have access to the industry leading Curaleaf Rewards program.

Curaleaf Completes Acquisition of Deseret Wellness

Retrieved on: 
Monday, April 10, 2023
City, CSE, Acquisition, Patient, Transaction, Retail, Curaleaf

NEW YORK, April 10, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the completion of its previously announced acquisition of Deseret Wellness ("Deseret"), the largest cannabis retail operator in Utah (the "Transaction"). With the close of the Transaction, Curaleaf's retail footprint has increased to four dispensaries in Utah and 150 nationwide.

Key Points: 
  • NEW YORK, April 10, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the completion of its previously announced acquisition of Deseret Wellness ("Deseret"), the largest cannabis retail operator in Utah (the "Transaction").
  • Boris Jordan, Executive Chairman of Curaleaf, stated, "Deseret is an excellent strategic fit for Curaleaf as we continue to expand our retail footprint in key emerging markets.
  • On behalf of the Board of Directors and management team, I am pleased to officially welcome Deseret to the Curaleaf family."
  • Matt Darin, CEO of Curaleaf, stated, "We are excited to complete our acquisition of Deseret which bolsters Curaleaf's medical footprint in Utah with an attractive portfolio of retail assets.